- Home
- Publications
- Publication Search
- Publication Details
Title
Glycopyrrolate and formoterol fumarate for the treatment of COPD
Authors
Keywords
-
Journal
Expert Review of Respiratory Medicine
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2020-08-08
DOI
10.1080/17476348.2020.1807946
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
- (2020) Klaus F. Rabe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Benralizumab for the Prevention of COPD Exacerbations
- (2019) Gerard J. Criner et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPD
- (2019) François Maltais et al. ADVANCES IN THERAPY
- A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol
- (2019) Klaus F. Rabe et al. RESPIRATORY MEDICINE
- Gamma scintigraphic pulmonary deposition study of glycopyrronium/formoterol metered dose inhaler formulated using co-suspension delivery technology
- (2018) Glyn Taylor et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
- (2018) Chen Wang et al. LANCET
- Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
- (2018) Alberto Papi et al. LANCET
- Cardiovascular safety profile of a fixed-dose combination of glycopyrrolate and formoterol fumarate delivered via metered dose inhaler using co-suspension delivery technology
- (2018) Gary T. Ferguson et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Randomized study of the effects of Aerochamber Plus ® Flow-Vu ® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease
- (2018) Faisal Fakih et al. RESPIRATORY MEDICINE
- Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD
- (2018) Gary T Ferguson et al. International Journal of Chronic Obstructive Pulmonary Disease
- Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD
- (2018) Colin Reisner et al. International Journal of Chronic Obstructive Pulmonary Disease
- Pharmacokinetics and safety of a single dose of the novel LAMA/LABA fixed-dose combination of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler, formulated using co-suspension delivery technology, in Japanese healthy subjects
- (2018) Colin Reisner et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD
- (2018) Wilfried De Backer et al. International Journal of Chronic Obstructive Pulmonary Disease
- Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA
- (2018) Brian J Lipworth et al. International Journal of Chronic Obstructive Pulmonary Disease
- Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial
- (2018) Gary T Ferguson et al. Lancet Respiratory Medicine
- Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial
- (2017) Jørgen Vestbo et al. LANCET
- Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease
- (2017) Nicola A. Hanania et al. RESPIRATORY MEDICINE
- Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2017) Joan B Soriano et al. Lancet Respiratory Medicine
- A Two-Period Open-Label, Single-Dose Crossover Study in Healthy Volunteers to Evaluate the Drug–Drug Interaction Between Cimetidine and Inhaled Extrafine CHF 5993
- (2016) Fabrizia Mariotti et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD
- (2016) Donald P. Tashkin et al. RESPIRATORY MEDICINE
- Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial
- (2016) Henrik Watz et al. Lancet Respiratory Medicine
- Imaging in Aerosol Medicine
- (2015) T. E. Corcoran Respiratory Care
- Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
- (2014) Helgo Magnussen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of cimetidine, a model drug for inhibition of the organic cation transport (OCT2/MATE1) in the kidney, on the pharmacokinetics of glycopyrronium
- (2013) Swati Dumitras et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started